Alivernini, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 3.240
EU - Europa 2.747
AS - Asia 1.776
SA - Sud America 447
AF - Africa 55
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 8.276
Nazione #
US - Stati Uniti d'America 3.170
SG - Singapore 706
CN - Cina 565
IT - Italia 559
SE - Svezia 458
BR - Brasile 396
PL - Polonia 391
DE - Germania 373
FR - Francia 282
IE - Irlanda 162
GB - Regno Unito 116
UA - Ucraina 96
IN - India 95
ID - Indonesia 92
FI - Finlandia 81
VN - Vietnam 63
RU - Federazione Russa 50
HK - Hong Kong 49
CA - Canada 37
TR - Turchia 35
BD - Bangladesh 31
BE - Belgio 30
AT - Austria 27
NL - Olanda 27
KR - Corea 26
MX - Messico 24
IQ - Iraq 21
JP - Giappone 21
ZA - Sudafrica 19
AR - Argentina 13
CI - Costa d'Avorio 13
IR - Iran 13
ES - Italia 12
LT - Lituania 12
IL - Israele 11
CH - Svizzera 9
EC - Ecuador 9
SA - Arabia Saudita 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
RO - Romania 8
GR - Grecia 7
PK - Pakistan 7
KE - Kenya 6
MA - Marocco 6
AU - Australia 5
CL - Cile 5
EE - Estonia 5
LV - Lettonia 5
MD - Moldavia 5
PE - Perù 5
MY - Malesia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
EU - Europa 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
LB - Libano 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 8.276
Città #
Chandler 508
Warsaw 370
Singapore 312
Ashburn 288
Fairfield 168
Rome 150
Dublin 144
New York 123
Wilmington 120
Beijing 110
Dearborn 104
Woodbridge 98
Ann Arbor 96
Seattle 93
Jakarta 90
Houston 78
Nanjing 72
Milan 70
Cambridge 68
Chicago 67
Munich 65
Cattolica 62
The Dalles 59
Jacksonville 55
Los Angeles 55
San Mateo 53
Boston 51
Princeton 50
Hefei 46
Hong Kong 46
Bremen 44
Marseille 35
Helsinki 33
London 32
São Paulo 32
Frankfurt am Main 30
Moscow 29
Redwood City 28
North Bergen 26
Brussels 24
Izmir 24
Pune 23
Redmond 22
Seoul 21
Nuremberg 20
Boardman 19
Lawrence 19
Nanchang 19
Hanoi 18
Kunming 16
Tianjin 16
Norwalk 15
Shenyang 15
Guangzhou 14
Hangzhou 14
Lancaster 14
Tokyo 14
Abidjan 13
Lappeenranta 13
Phoenix 13
Toronto 13
Turku 13
Salt Lake City 12
San Francisco 12
Vienna 12
Andover 11
Ho Chi Minh City 11
Roubaix 11
Dong Ket 10
Elk Grove Village 10
Hebei 10
Mountain View 10
San Diego 10
Santa Maria 10
Washington 10
Baghdad 9
Brasília 9
Busto Arsizio 9
Paris 9
Atlanta 8
Charlotte 8
Curitiba 8
Dhaka 8
Falkenstein 8
Fuzhou 8
Lauterbourg 8
Newark 8
Rio de Janeiro 8
Shanghai 8
Wroclaw 8
Augusta 7
Brooklyn 7
Catania 7
Jiaxing 7
Jinan 7
Johannesburg 7
Leawood 7
Nürnberg 7
Stockholm 7
Strasbourg 7
Totale 4.685
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 312
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 303
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 284
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 221
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 217
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 170
Synovial tissue macrophages: friend or foe? 167
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 164
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 155
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 144
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 142
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 137
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 130
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 122
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 120
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 120
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 120
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 117
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 115
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 114
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 112
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 112
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 110
Postural control and disability in patients with early rheumatoid arthritis 108
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 104
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 104
Sarilumab use in severe SARS-CoV-2 pneumonia 103
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 100
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 99
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 98
The pathogenesis of rheumatoid arthritis 97
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 95
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 93
Malnutrition in COVID-19 survivors: prevalence and risk factors 91
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 91
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 91
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 87
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 86
COVID-19 atypical Parsonage-Turner syndrome: a case report 85
Malnutrition in COVID-19 survivors: prevalence and risk factors 85
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 84
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 84
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 83
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 80
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 79
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 77
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 76
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 75
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 75
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 74
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 73
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 72
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 71
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 70
The B side of rheumatoid arthritis pathogenesis 70
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 70
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 69
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 69
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 67
Telemedicine will not keep us apart in COVID-19 pandemic 67
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 65
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 64
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 64
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 62
Bispecific T cell engager therapy for refractory rheumatoid arthritis 61
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 61
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 61
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 60
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 59
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 59
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 58
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 56
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 56
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 56
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 55
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 52
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 50
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 49
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 49
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 45
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 44
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 44
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 41
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 41
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 41
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 38
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 33
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 32
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 30
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 28
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 28
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 27
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 23
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 20
Totale 8.422
Categoria #
all - tutte 41.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021509 0 43 26 34 75 38 49 11 73 63 72 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/20252.054 36 38 152 97 149 83 90 88 303 230 391 397
2025/2026771 735 36 0 0 0 0 0 0 0 0 0 0
Totale 8.422